Amalgamated Bank’s Lucid Diagnostics LUCD Stock Holding History

Amalgamated Bank’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,832	Closed	-$3K	–	2302
2025 Q4	$3K	Buy	2,832 +468	+20%	+$523	﹤0.01%	2864
2025 Q3	$2K	Hold	2,364	–	–	﹤0.01%	2934
2025 Q2	$3K	Buy	+2,364	New	+$3.05K	﹤0.01%	2919
2022 Q2	–	Sell	-756	Closed	-$3K	–	3132
2022 Q1	$3K	Buy	+756	New	+$2.76K	﹤0.01%	3045

Other funds holding LUCD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Amalgamated Bank's LUCD Position: Q1 2026 in Review

Amalgamated Bank sold out of Lucid Diagnostics (LUCD) in Q1 2026, closing a stake of 2,832 shares — an estimated $3K sold.

Amalgamated Bank first reported a position in LUCD in Q1 2022 and held it in 4 quarters. The position peaked at $3K in Q4 2025. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

Amalgamated Bank reported no remaining Lucid Diagnostics position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 2,832 Lucid Diagnostics shares in Q1 2026, an estimated $3K.
Amalgamated Bank first reported a position in Lucid Diagnostics in Q1 2022 and held it in 4 quarters.
Amalgamated Bank's Lucid Diagnostics position peaked at $3K in Q4 2025.
103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.